Search Within

David Scheinberg

  1. "Elsevier Inc."
Formats
  1. Journal Article (14)
  2. Meeting Abstract (10)
Groups
  1. Adult Leukemia (24)
  2. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (24)
  3. Center for Hematologic Malignancies (24)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (24)
  5. Department of Medicine (24)
  6. GSK Faculty (24)

More Groups

People
  1. Joseph Jurcic (7)
  2. Alan Houghton (6)
  3. Michael Mcdevitt (3)
  4. Tao Dao (3)
  5. Jan Grimm (2)
  6. Martin Klatt (2)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2018 (1)
  4. 2017 (3)
  5. 2016 (1)
  6. 2014 (2)

More Years

Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (6)
  2. Cancer Chemotherapy and Biological Response Modifiers (4)
  3. European Journal of Cancer (3)
  4. Biology of Blood and Marrow Transplantation (2)
  5. Current Opinion in Immunology (2)
  6. Advances in Pharmacology (1)

More Publications

Publishers
  1. Elsevier Inc. (24)

Results (24)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A radiohapten capture system for CAR T cells that tracks them in vivo and improves efficacy
    Meeting Abstract

    Kurtz, K.; Eibler, L.; Dacek, M.; Carter, L.; Cheal, S.; Veach, D.; Qureshy, S.; Han, J.; Reynaud, E.; Verma, S.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • A tumor-agnostic TCR-mimic CAR-T cell specific for NDC80 targets multiple hematological malignancies
    Meeting Abstract

    Klatt, M. G.; Dao, T.; Yang, Z.; Liu, J.; Mun, S. S.; Dacek, M. M.; Luo, H.; Gardner, T. J.; Bourne, C.; Peraro, L.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Improved sensitivity and specificity for mutated and unmutated class I HLA ligand identifications lead to better immunotherapy target discovery
    Meeting Abstract

    Klatt, M.; Gejman, R.; Mun, S. S.; Dao, T.; Scheinberg, D.
    Clinical Lymphoma, Myeloma and Leukemia (2018)

    Fulltext@MSK | Save
  • Therapeutic TCR mimic monoclonal antibodies to intracellular oncogenic proteins
    Meeting Abstract

    Scheinberg, D. A.
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Trial in progress: A Phase I/II study of lintuzumab-Ac225 in older patients with untreated acute myeloid leukemia
    Meeting Abstract

    Jurcic, J. G.; Levy, M.; Park, J.; Ravandi, F.; Perl, A.; Pagel, J.; Smith, B. D.; Orozco, J.; Estey, E.; Kantarjian, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Advances in the clinical translation of nanotechnology
    Journal Article

    Scheinberg, D. A.; Grimm, J.; Heller, D. A.; Stater, E. P.; Bradbury, M.; McDevitt, M. R.
    Current Opinion in Biotechnology (2017)

    Fulltext@MSK | Save
  • CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopes
    Meeting Abstract

    Mathias, M.; Sockolosky, J.; Chang, A.; Liu, C.; Garcia, K.; Scheinberg, D.
    Clinical Lymphoma, Myeloma and Leukemia (2016)

    Fulltext@MSK | Save
  • Auxiliar treatment by targeting the extracellular matrix to improve drug delivery and therapeutic response
    Meeting Abstract

    Henke, E.; Roehrig, F.; Hoffmann, H.; Escorcia, F.; Wartenberg, M.; Volova, S.; Gaetzner, S.; Rosenwald, A.; Erguen, S.; Scheinberg, D. A.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • The Warburg effect confers adverse outcome in chronic lymphocytic leukemia
    Meeting Abstract

    Gardner, J. R.; Devlin, S. M.; Knapp, K.; Bauli, F.; Patel, M.; Lamanna, N.; Frattini, M. G.; Brentjens, R.; Maslak, P.; Jurcic, J. G.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • Will nanotechnology influence targeted cancer therapy?
    Journal Article

    Grimm, J.; Scheinberg, D. A.
    Seminars in Radiation Oncology (2011)

    Fulltext@MSK | Save